Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Olema Pharmaceuticals, Inc. market cap for the quarter ending 2026-08-06 was $1.03B, a 218.98% increase year-over-year.
Olema Pharmaceuticals, Inc. market cap for the quarter ending 2026-06-30 was $1.1B, a 274.66% increase year-over-year.
Olema Pharmaceuticals, Inc. market cap for the quarter ending 2026-05-07 was $1.32B, a 313.46% increase year-over-year.
Olema Pharmaceuticals, Inc. market cap for the quarter ending 2026-03-31 was $1.3B, a 406.97% increase year-over-year.
Olema Pharmaceuticals, Inc. market cap for fiscal 2026 was $1.03B.
Olema Pharmaceuticals, Inc. market cap for fiscal 2025 was $2.04B, a 370.14% increase from fiscal 2024.
Olema Pharmaceuticals, Inc. market cap for fiscal 2024 was $433.24M, a 43.85% decline from fiscal 2023.
Olema Pharmaceuticals, Inc. market cap for fiscal 2023 was $771.55M, a 681.68% increase from fiscal 2022.